Prosight Management, LP
DALLAS, TX · CIK 1617201 · 13F filing filed 2022-08-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityPROSIGHT MANAGEMENT, LP (US)
- Kindhedge funds
- Others nearbyDallas, TX
- FamilyProsight Management, LP · 2 related pages
Options: 1 call positions ($3.5m notional), 0 put positions (— notional) – listed below, not included above.
Also in the report of:
- APOGEM CAPITAL LLC – $8.9m of shares are in both reports
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| GALAPAGOS NV LKFT | $20.6m16.68% | Reduced -5.0k |
| PROTHENA CORP PLC PRTA | $14.9m12.10% | Reduced -16.5k |
| KEZAR LIFE SCIENCES INC COM | $10.4m8.46% | Added +962.7k |
| ALBIREO PHARMA INC BIOD | $9.3m7.52% | Reduced -12.2k |
| KALVISTA PHARMACEUTICALS INC KALV | $8.1m6.54% | Added +231.5k |
| ALDEYRA THERAPEUTICS INC ALDX | $7.9m6.42% | Added +585.6k |
| MEIRAGTX HLDGS PLC MGTX | $7.5m6.05% | Added +605.5k |
| CHARLES RIV LABS INTL INC CRL | $5.9m4.77% | Reduced -4.0k |
| 1LIFE HEALTHCARE INC COM | $5.7m4.60% | New |
| QUIDELORTHO CORP QDEL | $4.5m3.67% | New |
| SHATTUCK LABS INC STTK | $4.1m3.35% | Added +221.3k |
| CUE BIOPHARMA INC COM | $4.1m3.34% | Added +145.2k |
| ROCKET PHARMACEUTICALS INC RCKT | $3.8m3.09% | Added +73.5k |
| GLOBAL BLOOD THERAPEUTICS IN GBT | $3.3m2.64% | New |
| MIRUM PHARMACEUTICALS INC MIRM | $3.1m2.55% | Added +87.6k |
| TENET HEALTHCARE CORP THC | $2.7m2.16% | New |
| BIOCRYST PHARMACEUTICALS INC BCRX | $1.9m1.51% | New |
| ARS PHARMACEUTICALS INC SPRY | $1.4m1.17% | Added +15.7k |
| PROQR THRAPEUTICS N V PRQR | $1.3m1.08% | Added +1.1m |
| ARDELYX INC ARDX | $1.3m1.03% | New |
| INMODE LTD INMD | $1.0m0.82% | Reduced -5.0k |
| APOLLO ENDOSURGERY INC COM | $329.0k0.27% | New |
| COGNITION THERAPEUTICS INC CGTX | $254.0k0.21% | Reduced -119.9k |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| CONVEY HEALTH SOLUTIONS HLDG | $4.9m748.1k shares |
| ALNYLAM PHARMACEUTICALS INC ALNY | $3.7m22.7k shares |
| AGILON HEALTH INC | $3.5m140.0k shares |
| QUIDEL CORP QDEL | $2.9m25.7k shares |
| ENCOMPASS HEALTH CORP EHC | $2.8m39.9k shares |
| OSCAR HEALTH INC OSCR | $2.4m237.5k shares |
| ACCOLADE INC ACCD | $2.2m124.4k shares |
| SELECT MED HLDGS CORP SEM | $2.2m90.8k shares |
| CRISPR THERAPEUTICS AG CRSP | $2.1m34.0k shares |
| GLOBUS MED INC GMED | $1.3m18.0k shares |
| NEOGENOMICS INC NEO | $772.0k63.5k shares |
| SIO GENE THERAPIES INC AXON | $449.0k670.3k shares |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $333.0k20.0k shares |
| CYMABAY THERAPEUTICS INC CBAY | $292.0k93.9k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| 1LIFE HEALTHCARE INC Call | $3.5m440.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| SHATTUCK LABS INC STTK · 13G · filed 2025-11-13 | 9.9%≈ $45.4m |
| ADC THERAPEUTICS SA ADCT · 13G · filed 2026-02-13 | 6.8%≈ $9.1m |
| JANUX THERAPEUTICS INC JANX · 13G · filed 2026-02-06 | 5.3%≈ $48.5m |